SCHEMBL19851100

SCHEMBL19851100

CCOC(=O)CSc1nc2cccnc2n1-c1cccc2ccccc12

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.66
LMNA P02545 1/20 0.66
ALDH1A1 P00352 8/20 0.58
SMN1; SMN2 Q16637 4/20 0.58
HPGD P15428 4/20 0.58
MAPT P10636 2/20 0.58
MAPK1 P28482 3/20 0.58
PDE10A Q9Y233 1/20 0.54
ALOX15 P16050 1/20 0.53
KDM4E B2RXH2 2/20 0.52
CYP1A2 P05177 1/20 0.52
CYP3A4 P08684 1/20 0.52
CYP2C9 P11712 1/20 0.52
PSMD14 O00487 1/20 0.51
GAA P10253 1/20 0.51
NPSR1 Q6W5P4 1/20 0.51
ATM Q13315 1/20 0.51
MEN1 O00255 1/20 0.50
RECQL P46063 1/20 0.50
KMT2A Q03164 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19851102 0.89 TSHR (0.52) TSHRLMNAALDH1A1SMN1; SMN2HPGD
SCHEMBL19851022 0.86 TSHR (0.59) TSHRLMNAALDH1A1SMN1; SMN2HPGD
SCHEMBL19851103 0.85 ALDH1A1 (0.53) TSHRLMNAALDH1A1HPGDMAPT
SCHEMBL19851096 0.84 TSHR (0.56) TSHRLMNAALDH1A1SMN1; SMN2HPGD
SCHEMBL19851101 0.83 ALDH1A1 (0.48) TSHRLMNAALDH1A1SMN1; SMN2HPGD
SCHEMBL21093621 0.83 ALDH1A1 (0.49) TSHRLMNAALDH1A1SMN1; SMN2HPGD
SCHEMBL19851099 0.80 TSHR (0.68) TSHRLMNAALDH1A1SMN1; SMN2HPGD
SCHEMBL21093719 0.79 TSHR (0.57) TSHRLMNAALDH1A1SMN1; SMN2HPGD
SCHEMBL21093540 0.79 ALDH1A1 (0.46) TSHRLMNAALDH1A1SMN1; SMN2HPGD
SCHEMBL21189138 0.78 ALDH1A1 (0.46) TSHRLMNAALDH1A1SMN1; SMN2HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3495362-B1 IMIDAZOPYRIDINE THIOGLYCOLIC ACID DERIVATIVE, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF UNIV SHANDONG (CN) 2021-10-27 EP disclosed
US-10399978-B2 Imidazopyridine thioglycolic acid derivatives as potent inhibitors of human urate transporter 1 SHANDONG UNIVERSITY (CN) 2019-09-03 US disclosed
US-20190225606-A1 Novel Imidazopyridine Thioglycolic Acid Derivatives as Potent Inhibitors of Human Urate Transporter 1 SHANDONG UNIVERSITY (CN) 2019-07-25 US disclosed
EP-3495362-A1 IMIDAZOPYRIDINE THIOGLYCOLIC ACID DERIVATIVE, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF Shandong University (CN) 2019-06-12 EP disclosed
WO-2018023851-A1 IMIDAZOPYRIDINE THIOGLYCOLIC ACID DERIVATIVE, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF 山东大学 2018-02-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190225606-A1 Novel Imidazopyridine Thioglycolic Acid Derivatives as Potent Inhibitors of Human Urate Transporter 1 SLC29A1, SLC28A1, SLC5A1 TSHR 2731/4885LMNA 4231/4885ALDH1A1 446/4885
US-10399978-B2 Imidazopyridine thioglycolic acid derivatives as potent inhibitors of human urate transporter 1 SLC29A1, SLC28A1, SLC5A1 TSHR 2444/4885LMNA 3991/4885ALDH1A1 473/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.